Receipt of the measles-mumps-rubella vaccine was not associated with increased risk of autism spectrum disorders, even for children who had an older sibling with autism, according to a study of nearly 100,000 children, published in JAMA.
Breethe Inc has obtained exclusive rights to develop a wearable, portable blood pump oxygenator that will function as an artificial lung system for patients suffering from cardiopulmonary collapse and respiratory failure.
Researchers explored the previously unproven role of the calcium sensing receptor (CaSR) in causing asthma, a disease which affects 300 million people worldwide.
Telehealth industry groups are expecting increases in Medicare reimbursement for remote patient monitoring services.
Alternative payment models seek to change the industry practice of fee-for-service payments to emergency departments and replace it with per-case or per-person payments.
A USA Today report discusses the high number of health problems experienced by EMS workers who responded to the terrorist attacks at the World Trade Center in 2001, including breathing problems and depression.
Pneumonia, acute bronchitis, and asthma were the three most common causes of hospitalization in 2012 for children under the age of 18.
Narhex Life Sciences Ltd is currently recruiting patients for a clinical trial of ResApp, the world's first cough diagnosis smartphone app.
The Oklahoma Center for Respiratory and Infectious Diseases (OCRID) is becoming a focal point for respiratory infectious disease research in the state.
MedCity News reports that AstraZeneca has signed a 5-year agreement with PatientsLikeMe, a patient-powered research network.
Nihon Kohden has appointed Dr Wilson P. Constantine the new chief executive officer of Nihon Kohden America.
This ABC News article describes the differences between several types of cough and the potential reason behind them, including asthma, COPD and other conditions.
Scientists have discovered a new isoform which could be involved both in the pathogenesis of pulmonary emphysema as well as in the failure of some therapy approaches.
MedImmune has received fast track designation from the FDA for the development of MEDI8897, which is being investigated for use in infants and young children with RSV.
A MedCity News report indicates Nabriva Therapeutics have raised more than $100 million for drugs that treat highly resistant bacterial infections.
Salinas Valley Memorial Healthcare System in Salinas, Calif, has earned 2015 Quality Respiratory Care Recognition from the American Association for Respiratory Care.
The School of Health Professions at the University of Texas Health Science Center at San Antonio will offer a new master of science degree in respiratory care beginning this fall.
The ATS and ERS have published a statement describing the state of current evidence on the diagnosis, assessment, and management of COPD, including recommendations for future research.
Drive Medical, a global manufacturer of durable medical equipment, has acquired two healthcare device manufacturers: Columbia Medical in the US and Park House Healthcare in Europe.
Recommendations from the new guidelines include omitting use of bronchodilators and allowing clinicians to omit use of pulse oximetry.